SMCI Approaching Key Reversal Zone – Breakout or More Downside?
157
Technical Analysis (TA): 1. Trend & Structure: * SMCI has been in a strong downtrend, marked by multiple Break of Structure (BOS) signals. * A Change of Character (ChoCH) has occurred, hinting at a potential reversal if confirmed. * Resistance: ~43 (Call Resistance), 57-60 (Major Supply Zone). * Support: ~35-38 (Demand Zone & Highest Negative NETGEX). 2. Reversal Zone: * The 35-38 range is a key demand area where buyers have previously stepped in. * If SMCI holds above 38, it has potential to test 43 before further upside. * A failure to hold 38 could see retesting 35 or lower. 3. Indicators: * MACD: Neutral, with potential for a bullish cross. * Stochastic RSI: Oversold, signaling possible upward momentum. * Volume: Increased buying near the 38 level suggests accumulation.
Options GEX & Trade Setup: 1. Call Walls (Resistance): * 43 – First resistance where price may stall. * 57-60 – If price clears 43, gamma resistance intensifies. 2. Put Walls (Support): * 38 – Highest negative NETGEX support, critical for reversal. * 35 – 2nd major Put Wall; a break here could accelerate downside. 3. Option Trade Suggestions: * Bullish Play: If price holds above 38 and starts breaking 40, consider April 40C or 45C targeting 43-45. * Bearish Play: If SMCI breaks below 38 with weakness, consider March-April 35P targeting 35 or lower.
Thoughts & Conclusion: SMCI is at a critical decision point around 38. If it reclaims 40, it could push toward 43-45, but failure to hold 38 could send it lower to 35. Traders should wait for confirmation of either a breakout or breakdown before committing to a trade.
Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Always do your own research and manage risk accordingly.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.